Priced For Impairment

Priced For Impairment

The four acts before this one built the machine, watched its growth engine stall, weighed management's word against its record, and followed the cash into a record buyback. Each deferred the same thing: the price. Gartner trades at roughly $140, down 74.6% from a November-2024 high of $551.80, and the striking feature of that collapse is what did not fall with it. Forward earnings estimates are higher today than they were a quarter ago; the company still converts a 68%-plus gross margin into free cash flow well in excess of net income; guided revenue for 2026 is essentially flat, not shrinking. The decline is almost entirely the multiple. That is the fact this chapter has to explain — and the reason the cyclical-versus-structural question the tape has refused to settle is worth stating precisely rather than resolving by assertion.

A Company-Specific Re-Rating

A 74.6% drawdown is not, by itself, evidence of anything: broad sectors de-rate, and a research-and-data business could simply be moving with its group. The peer set says otherwise. Across the six names Gartner's own filings and the screen put beside it, the median drawdown from a trailing three-year high is 44.4%. Gartner's is 30 points deeper than that median — the second-worst in the group, behind only Clarivate — while the ratings-and-data majors that share its subscription economics barely moved: SPGI is off 20.1%, Informa 11.0%.

Source: price feeds as reported; drawdown from each name's trailing 3-year high, 2026-07-17; peer median −44.4%.

The read is that the market is pricing something particular to Gartner, not repricing information services as a class. A rates move or a sector rotation would have carried SPGI and Informa down with it; it did not. Whatever the tape is discounting, it is a Gartner-specific concern — which the next section narrows further.

The Decline Is the Multiple, Not the Earnings

The two down-moves that did most of the damage share an unusual signature: both landed on earnings beats. On August 5, 2025 the stock fell 27.6% in a day, from $336.71 to $243.93, after a quarter in which adjusted EPS of $3.53 beat the $3.31 consensus by 6.8%. On February 3, 2026 it fell another 20.9%, from $202.40 to $160.16, on a Q4 in which adjusted EPS of $3.94 beat $3.51 by 12.2% [1]. Prices fall on beats when the market marks down the forward model rather than the delivered quarter — here, the contract-value engine whose stall The Engine Stalled diagnosed.

Source: consensus and surprise per consensus feed; the Q4 result [2]; daily price moves as reported.

The clinching evidence that this is compression, not deterioration, sits in the estimate revisions. Over the window in which the shares fell from a January-2026 high near $248 to roughly $140 — a 43% slide — consensus normalized EPS did not follow them down. It went up: the 2026 estimate rose from $13.15 ninety days ago to $13.68, and the 2027 estimate from $14.72 to $15.31. The numerator held while the multiple halved again.

Source: consensus normalized EPS trend per consensus feed; share prices as reported.

Two things can be true at once, and both are. Each guidance update that accompanied a beat was soft — a lowered 2025 revenue outlook in August, a 2026 adjusted-EPS guide of $12.30 or more in February that sits below the $13.17 the company just delivered [3]. Yet analysts, looking past a guide that management built conservatively, marked their multi-year normalized numbers higher. The market repriced the durability of the model, not the earnings it is currently producing.

What $140 Capitalizes

At $140.19 the market values Gartner's equity at $10.6 billion and, with $1.26 billion of net debt, the enterprise at roughly $11.9 billion. Against consensus, that is about 10.2 times 2026 normalized EPS of $13.68, 10.9 times GAAP EPS of $12.90, and 7.5 times 2026 EBITDA — with a free-cash-flow yield near 11% on both trailing and forward cash generation.

Source: market cap and net debt as reported; consensus 2026 normalized EPS, EBITDA and free cash flow per consensus feed; drawdown from trailing 3-year high.

The reason this multiple is worth dwelling on is the base it sits on. This is not a cyclical manufacturer at 10 times a peak. It is the recurring, prepaid subscription franchise laid out in The Cash Machine, still earning a 77% contribution margin on its Insights core, against guided 2026 revenue of $6.455 billion or more — flat to slightly higher on an FX-neutral basis versus 2025's $6.5 billion, with consensus modeling a 1.1% decline [4]. A near-11% cash yield with revenue roughly flat and EPS estimates rising is the arithmetic of a business the market has decided will not grow — and may quietly shrink — for a long time.

That arithmetic frames the two sides without deciding between them. A buyer at $140 collects a near-11% free-cash-flow yield and needs only for the franchise to hold its cash generation roughly flat; the price implies the federal cancellations lap, the AI threat is overstated or already discounted, and the contract value outside the U.S. federal government that still grew 4% in the fourth quarter is the real trend line [5]. A seller at the same price reads 10 times earnings as generous for an annuity that is beginning to melt: wallet retention has crossed below 100% — 96% at GTS, 99% at GBS — and total Insights contract value grew just 1%, the leading indicators of a base that spends less each year even as its logos stay [6].

My own read, offered once: the reported and guided record shows deceleration, not shrinkage — flat-to-positive FX-neutral revenue, a 77% contribution margin intact, rising consensus EPS, and cash conversion still above net income — so at 10 times earnings the price embeds a durable impairment the numbers have not yet corroborated. The strongest fact against that read is the one the bear leads with: wallet retention below 100% and flat contract value are precisely the metrics that would confirm structural shrinkage if they persist, and they are moving the wrong way. What would change the read is the contract-value trajectory over the next few quarters, which is where the evidence, not the rhetoric, will land.

The Sell Side, Uncommitted

The analysts who cover Gartner have not resolved this either, and their posture is its own data point. Their price targets cluster modestly above the stock — a mean of $162 and median of $164, roughly 16-17% above spot — with a high of $203 and a low of $120, so the current price sits only about 17% above the most bearish target on the sheet.

Source: analyst price-target distribution per consensus feed; spot $140.19 as reported (2026-07-17).

The recommendation mix is where the hesitation shows. Against those targets, the ratings are one strong buy, three buys, nine or ten holds, one sell and one strong sell — a consensus recommendation score of 2.8, squarely in hold territory. Modeled upside on paper, no conviction to back it. The sell side is, in effect, saying it does not know whether the de-rating overshot — the same uncertainty the price itself carries.

What Would Settle It

The honest state of the case is that the cyclical and structural stories are not yet separable from the reported numbers — but they are separable by evidence that arrives on a schedule. Four tests will do the separating, each tied to a line item, the filing it appears in, and a threshold that would move the read one way or the other.

Source: contract-value and retention KPIs [7]; U.S. federal exposure [8]; 2026 share-count assumption [9].

The first test is the cleanest. Roughly $126 million of Insights contract value sat with the U.S. federal government at year-end 2025, and less than half of the prior year's federal book was retained through the cancellations that followed the federal cost-cutting drive [10]. Management guides contract-value growth to accelerate through 2026 largely on that book annualizing; on its own math, removing the federal headwind with no assumption for net growth adds back around 200 basis points of CV growth [11]. If ex-federal contract value keeps compounding and total CV reaccelerates, the federal drag was a cyclical air pocket. If total CV stays pinned near 1% after the federal base laps, the weakness was never mostly federal.

The second test is the one that cannot be scheduled as neatly, and it is where the structural fear lives. Gartner's own 10-K names the mechanism plainly: large language models "provide substantive content in search results" that "could reduce the need to enter our websites," and clients loading proprietary Gartner content into an LLM "could reduce the value of our offerings" [12]. The same filing markets AI as growth — AskGartner, launched in August 2025, is positioned as a demand driver [13]. It is the battleground the whole category names; Forrester, Gartner's weakest direct peer, is organizing its defense around the same claim that proprietary, trusted content resists substitution. Wallet retention is the scoreboard: back above 100% would say a Gartner seat is worth more, not less, as AI proliferates; a further leg down would say the opposite.

The third and fourth tests measure whether management's responses work. The salesforce is the machinery behind contract value, and the cost discipline that protected 2025 margins — quota-bearing headcount guided to only low-single-digit growth at GTS and mid-single at GBS for 2026 [14] — either preserves selling capacity or quietly hollows it; new-business dollars, still running down about 5% outside the federal book, are the tell [15]. And the leveraged, all-in repurchase of The Buyback Bet has a built-in accretion test: the 2026 guide assumes buybacks only to offset dilution and less interest income, so realized EPS should clear $12.30 if the company keeps shrinking the count — while debt that rises without an EPS lift would mean the bet concentrated an impairing position rather than compounding value [16].

None of these is settled today, which is the accurate place to end. The price at $140 pays a near-11% cash yield to wait for the answers, and asks in return that the reader accept a franchise whose forward moat metrics are eroding at the same time its per-share cash claim is being concentrated. The case is most sensitive to the contract-value line — the metric that turns the cyclical story into the structural one, or back again — and it prints four times a year.